086900 — Medy Tox Cashflow Statement
0.000.00%
- KR₩1tn
- KR₩1tn
- KR₩221bn
- 72
- 11
- 23
- 24
Annual cashflow statement for Medy Tox, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 25,563 | -30,039 | 93,263 | 36,596 | 9,690 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 17,484 | 29,264 | -46,487 | 22,689 | 16,683 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -27,485 | 10,104 | -44,758 | -47,880 | -27,958 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 33,703 | 27,927 | 19,966 | 26,169 | 13,503 |
Capital Expenditures | -23,664 | -44,306 | -21,344 | -25,101 | -37,469 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -4,727 | -7,718 | -6,433 | -11,023 | 50,724 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -28,391 | -52,024 | -27,777 | -36,124 | 13,255 |
Financing Cash Flow Items | -927 | -2,991 | -3,648 | -2,077 | -3,794 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -4,482 | 50,718 | 34,804 | -40,388 | -13,544 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 769 | 23,977 | 27,784 | -51,089 | 12,558 |